December 5, 2019 –
FDA launches app for health care professionals to report novel uses of existing medicines for patients with difficult-to-treat infectious diseases
The U.S. Food and Drug Administration today announced the global launch of CURE ID, an internet-based repository that will allow the clinical community to report their experiences treating difficult-to-treat infectious diseases with novel uses of existing FDA-approved drugs through a website, a smartphone or other mobile device. The platform enables the crowdsourcing of medical information from health care providers to guide potentially life-saving interventions and facilitate the development of new drugs for neglected diseases. The repository is a collaboration between the FDA and the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH)…


Fondation Merieux [to 7 Dec 2019]
News, Events
20 – 22 Jan 2020
Mérieux Foundation co-organized event
Dengue pre-vaccination screening strategies workshop
Les Pensières Center for Global Health, Veyrier-du-Lac (France)


Gavi [to 7 Dec 2019]
5 December 2019
Gavi Board approves new Ebola vaccine programme
[See Ebola above for detail]

5 December 2019
Gavi Board appoints Sarah Goulding as Vice Chair
New Delhi, 5 December 2019 – Sarah Goulding, Assistant Secretary, Education, Social Protection and Human Development Finance at the Australian Department of Foreign Affairs and Trade (DFAT), was appointed by the Gavi Board as its new Vice Chair effective as of 1st January 2020.
“It is an honour to be appointed Vice Chair of the Gavi Board, at a time when Gavi is embarking on its new strategy for 2021-2025”, said Sarah Goulding. “I look forward to supporting the Board Chair at this critical time for the Vaccine Alliance, focusing on leaving no one without immunisation. Gavi’s mission to protect millions against life-threatening diseases is critically important for the most vulnerable children in the world’s poorest countries. This year, outbreaks of vaccine-preventable diseases including measles in places as diverse as DRC, Pakistan and Samoa shows the ongoing importance of vaccination globally.”
Sarah Goulding is currently the Gavi Board member for the United States, Australia, Japan and Republic of Korea constituency…


GHIT Fund [to 7 Dec 2019]
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that No new digest content identified.


Global Fund [to 7 Dec 2019]
News & Stories
Sourcing & Management of Health Products
Withdrawal of the Quality Assurance Information Notice 2018-02 Regarding Dolutegravir
06 December 2019

42nd Board Meeting Documents
05 December 2019

Data Service: Performance Framework Data
03 December 2019
Performance framework data from Global Fund grants are now available for download from the Global Fund Data Service.
The new data set lists indicator targets and results for grant implementation periods from the 2017-2019 allocation period and going forward. A number of grants from the previous allocation period are also included…


Hilleman Laboratories [to 7 Dec 2019]
No new digest content identified.


Human Vaccines Project [to 7 Dec 2019]
Press Releases
No new digest content identified.


IAVI [to 7 Dec 2019]
No new digest content identified.


International Coalition of Medicines Regulatory Authorities [ICMRA]
Selected Statements, Press Releases, Research
No new digest content identified.


International Generic and Biosimilar Medicines Association [IGBA]
05 December 2019
IGBA applauds long-awaited scientific harmonization process of bioequivalence studies
The International Generic and Biosimilar Medicines Association (IGBA) welcomes the adoption by the International Council for Harmonization (ICH) of a new topic proposal on Bioequivalence for ImmediateRelease Solid Oral Dosage Forms (M13)i . The ICH Assembly approved the Concept Paper Outline in their November Singapore meeting with the establishment without delay of a new Working Group to initiate work on finalizing the concept paper and business plan for this new topic…bioequivalence studies establish the efficacy and safety of most generic medicines and are an essential part of their development. Scientific harmonization of the study design of bioequivalence studies will allow the streamlining of some important aspects of the conduct of these trials and optimize product development…


No new digest content identified.


IFRC [to 7 Dec 2019]
Selected Press Releases, Announcements
No new digest content identified.


IVAC [to 7 Dec 2019]
No new digest content identified.


IVI [to 7 Dec 2019]
Selected IVI News & Announcements
No new digest content identified.


JEE Alliance [to 7 Dec 2019]
Selected News and Events
No new digest content identified.


MSF/Médecins Sans Frontières [to 7 Dec 2019]
Latest [Selected Announcements]
Democratic Republic of Congo
As security situation deteriorates, MSF withdraws staff from Biakato
Statement 6 Dec 2019
On 4 December 2019, Medecins Sans Frontières (MSF) took the painful decision to temporarily withdraw our staff from the Biakato region of Ituri province, Democratic Republic of Congo. After months of working extremely closely with the community to address the health needs in the region, MSF is saddened to have made this decision….

DRC Ebola outbreaks
Crisis update – December 2019
Crisis Update 6 Dec 2019

Access to medicines
Pharma giants shouldn’t receive multi-million dollar pneumonia vaccine subsidy
Press Release 3 Dec 2019
:: MSF is urging Gavi to stop paying pharma giants Pfizer and GSK subsidies for their pneumonia vaccines.
:: The vaccines protect against pneumonia, which kills nearly 1 million children each year.
:: The pharma giants earn billions off their vaccines and have been receiving subsidies as an ‘incentive’ to introduce them in developing countries.
:: The vaccines nevertheless remain too expensive for many countries to introduce, thanks to high prices – leaving young lives unprotected against the disease.
:: MSF urges Gavi to instead support the introduction of a more affordable pneumonia vaccine, coming to market soon.

New model of care aims to reduce deaths among advanced HIV patients
Project Update 1 Dec 2019

AIDS death toll stagnating due to lack of testing at community l…
Press Release 1 Dec 2019


National Vaccine Program Office – U.S. HHS [to 7 Dec 2019]
NVAC 2020 Meetings
February 13-14, 2020 NVAC Meeting
June 9-10, 2020 NVAC Meeting
September 23-24, 2020 Meeting (Virtual)


NIH [to 7 Dec 2019]
Selected News Releases
No new digest content identified.


PATH [to 7 Dec 2019]
Selected Announcements
PATH statement on the World Health Organization’s World Malaria Report, 2019
Focusing care on pregnant women and children will help accelerate progress toward malaria elimination; A statement from PATH’s Director of Malaria and Neglected Tropical Diseases, Center for Malaria Control and Elimination, Kammerle Schneider
December 4, 2019

PATH names Mr. Nikolaj Gilbert as President and CEO
The team of innovators, headquartered in Seattle, welcomes global development expert to lead ambitious efforts to improve health outcomes for more than 1.4 billion people by 2030
December 4, 2019


Sabin Vaccine Institute [to 7 Dec 2019]
Statements and Press Releases
No new digest content identified.


UNAIDS [to 7 Dec 2019]
Selected Press Releases/Reports/Statements
5 December 2019
Desert AIDS Project delegation visits health-care centre on the sidelines of ICASA

Communities hailed during South Africa’s World AIDS Day commemoration

Commemorating World AIDS Day in Belgium

4 December 2019
Ending stigma and discrimination is critical to expanding HIV services in Jamaica

3 December 2019
Remembering the leadership of Charlot Jeudy

UNAIDS staff member breaks gruelling world record

ICASA conference opens in Rwanda with an emphasis on African leadership

2 December 2019
Ending AIDS is everyone’s business

HIV treatment numbers continue to rise

UN Cares: putting people first in Jamaica’s HIV response

1 December 2019
World AIDS Day 2019: Speech by UNAIDS Executive Director Winnie Byanyima


UNICEF [to 7 Dec 2019]
Selected Statements, Press Releases, Reports
Press release
Measles outbreaks continue unabated : Five countries accounted for nearly half of all measles cases in 2018
Children in Samoa are latest victims of 2019 outbreaks

Press release
More than 140,000 die from measles as cases surge worldwide
Infants and young children most at risk of fatal complications, health agencies warn


Vaccination Acceptance Research Network (VARN) [to 7 Dec 2019]
No new digest content identified.


Vaccine Confidence Project [to 7 Dec 2019]
No new digest content identified.


Vaccine Education Center – Children’s Hospital of Philadelphia [to 7 Dec 2019]
No new digest content identified.


Wellcome Trust [to 7 Dec 2019]
News | 3 December 2019
Mosaic to close after five years of award-winning long-form journalism


The Wistar Institute [to 7 Dec 2019]
No new digest content identified.

World Organisation for Animal Health (OIE) [to 7 Dec 2019]
No new digest content identified.



ARM [Alliance for Regenerative Medicine] [to 7 Dec 2019]
No new digest content identified.


BIO [to 7 Dec 2019]
Press Release
More than 135 Emerging Biotech Leaders Urge Congress to Reject H.R. 3 
“Our continued success depends on maintaining an environment that supports investment in tomorrow’s discoveries.”
December 5, 2019


DCVMN – Developing Country Vaccine Manufacturers Network [to 7 Dec 2019]
No new digest content identified.


IFPMA [to 7 Dec 2019]
Selected Press Releases, Statements, Publications
No new digest content identified.


PhRMA [to 7 Dec 2019]
Selected Press Releases, Statements
Press Release
PhRMA Names Anne Esposito Senior Vice President of Federal Advocacy
Esposito to Lead Association’s Federal Advocacy Team
Washington, D.C. (December 5, 2019) — Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) named Anne Esposito as senior vice president of federal advocacy, effective January 2020. Esposito will oversee the association’s federal government affairs and succeeds Scott Olsen, who is retiring.
“Anne’s extensive experience provides her with the strategic leadership needed to build upon our successful advocacy to advance public policy reforms that address patient affordability challenges and foster innovation,” said PhRMA president and CEO Stephen J. Ubl. “Her ability to work on a bipartisan basis with stakeholders across the health care system is a vital addition to the association.”…